North Star Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.31M | Sell |
16,560
-50
| -0.3% | -$3.76K | 0.05% | 180 |
|
|
2026
Q1 | $1.25M | Hold |
16,610
| – | – | 0.05% | 177 |
|
|
2025
Q4 | $1.31M | Hold |
16,610
| – | – | 0.05% | 171 |
|
|
2025
Q3 | $1.09M | Hold |
16,610
| – | – | 0.04% | 184 |
|
|
2025
Q2 | $656K | Buy |
16,610
+3,000
| +22% | +$98.2K | 0.03% | 209 |
|
|
2025
Q1 | $411K | Sell |
13,610
-30
| -0.2% | -$982 | 0.02% | 233 |
|
|
2024
Q4 | $477K | Hold |
13,640
| – | – | 0.02% | 220 |
|
|
2024
Q3 | $546K | Hold |
13,640
| – | – | 0.02% | 213 |
|
|
2024
Q2 | $650K | Hold |
13,640
| – | – | 0.03% | 192 |
|
|
2024
Q1 | $591K | Sell |
13,640
-10
| -0.1% | -$477 | 0.03% | 200 |
|
|
2023
Q4 | $691K | Buy |
13,650
+10
| +0.1% | +$479 | 0.04% | 185 |
|
|
2023
Q3 | $619K | Hold |
13,640
| – | – | 0.04% | 189 |
|
|
2023
Q2 | $560K | Sell |
13,640
-40
| -0.3% | -$1.54K | 0.03% | 194 |
|
|
2023
Q1 | $489K | Hold |
13,680
| – | – | 0.03% | 205 |
|
|
2022
Q4 | $517K | Hold |
13,680
| – | – | 0.03% | 203 |
|
|
2022
Q3 | $605K | Hold |
13,680
| – | – | 0.04% | 180 |
|
|
2022
Q2 | $506K | Hold |
13,680
| – | – | 0.03% | 191 |
|
|
2022
Q1 | $507K | Hold |
13,680
| – | – | 0.03% | 209 |
|
|
2021
Q4 | $416K | Hold |
13,680
| – | – | 0.02% | 227 |
|
|
2021
Q3 | $459K | Sell |
13,680
-73
| -0.5% | -$2.75K | 0.03% | 216 |
|
|
2021
Q2 | $549K | Hold |
13,753
| – | – | 0.03% | 203 |
|
|
2021
Q1 | $618K | Sell |
13,753
-20
| -0.1% | -$1.11K | 0.04% | 186 |
|
|
2020
Q4 | $779K | Hold |
13,773
| – | – | 0.05% | 163 |
|
|
2020
Q3 | $654K | Buy |
13,773
+73
| +0.5% | +$4.05K | 0.05% | 166 |
|
|
2020
Q2 | $808K | Hold |
13,700
| – | – | 0.06% | 148 |
|
|
2020
Q1 | $648K | Sell |
13,700
-1,500
| -10% | -$83.6K | 0.06% | 152 |
|
|
2019
Q4 | $918K | Hold |
15,200
| – | – | 0.07% | 154 |
|
|
2019
Q3 | $911K | Hold |
15,200
| – | – | 0.07% | 151 |
|
|
2019
Q2 | $977K | Hold |
15,200
| – | – | 0.08% | 151 |
|
|
2019
Q1 | $1.23M | Hold |
15,200
| – | – | 0.1% | 134 |
|
|
2018
Q4 | $822K | Hold |
15,200
| – | – | 0.08% | 152 |
|
|
2018
Q3 | $784K | Hold |
15,200
| – | – | 0.06% | 168 |
|
|
2018
Q2 | $633K | Hold |
15,200
| – | – | 0.05% | 182 |
|
|
2018
Q1 | $670K | Hold |
15,200
| – | – | 0.06% | 172 |
|
|
2017
Q4 | $765K | Buy |
+15,200
| New | +$834K | 0.07% | 163 |
|
Other funds holding IONS
North Star Asset Management's IONS Position: Q2 2026 in Review
North Star Asset Management reduced its Ionis Pharmaceuticals (IONS) stake by 0.3% in Q2 2026, selling an estimated $3.76K and leaving 16,560 shares worth $1.31M. The position accounts for 0.05% of the portfolio, ranked #180.
North Star Asset Management first reported a position in IONS in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.31M in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- North Star Asset Management held 16,560 shares of Ionis Pharmaceuticals worth $1.31M as of Q2 2026.
- North Star Asset Management sold 50 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.76K.
- Ionis Pharmaceuticals made up 0.05% of North Star Asset Management's portfolio in Q2 2026, its #180 holding.
- North Star Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
- North Star Asset Management's Ionis Pharmaceuticals position peaked at $1.31M in Q4 2025.
- 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.